The outcome of IHE initiatives is providing better information for developing health policy and best medical practices. IHE disseminates information in many ways. In addition to publications in peer-reviewed journals, IHE produces books and a variety of reports synthesizing information in a particular field.
If you cannot find the publication or report you are seeking, please contact us at [email protected]. Thank you!
Refine your search by clicking filters to the left.
Results for: 2020
The IHE is pleased to receive support from Western Economic Diversification to help Life Sciences companies with promising market-ready innovations to make a stronger economic case for market access. The Institute of Health Economics (IHE) is receiving $953,250 in WD funding over three years to support approximately 30 western Canadian health companies with customized economic…
Established by the President of the Royal Society of Canada in April 2020, the RSC Task Force on COVID-19 was mandated to provide evidence-informed perspectives on major societal challenges in response to and recovery from COVID-19. The Task Force established a series of Working Groups to rapidly develop Policy Briefings, with the objective of supporting policy makers with evidence…
The Royal Society of Canada Task Force on COVID-19 was established early in 2020 to equip Canadians with accurate information about Canadian response and recovery. A number of Working Groups were established included one on COVID-19 and Economic Recovery which is chaired by the Institute of Health Economics’ CEO, Dr. Chris McCabe. Their report, "Renewing the Social Contract:…
The Institute of Health Economics (IHE) is recruiting to support the Health Economics team's growing portfolio of work with government and non-profit research sponsors. We are seeking candidates with experience in economic modelling, to undertake work in the design and conduct of economic evaluations in health care. We would encourage any early and mid-level career professionals…
The Institute for Health Economics (IHE) is conducting an invitational, virtual policy roundtable on progressive fibrosing interstitial lung disease (PF-ILD) on November 20th, 2020. This policy roundtable will seek to gain multi-stakeholder consensus on policy recommendations intended to optimize care for PF-ILD patients Key areas for discuss are in the following three areas: Multi-disciplinary…
Dr. Chris McCabe, CEO of IHE, along with colleagues Dr. Richard Gold and Dr, Aled Edwards, discuss priorities to support economic recovery post-COVID-19 in an editorial in the November 30th, 2020 Globe and Mail. The priorities identified are 1) labour market transition; 2)…
The IHE is pleased to have collaborated with global health industry leaders in launching the UNIVANTS of Healthcare Excellence awards and to announce the 2020 award winners. The UNIVANTS of Healthcare Excellence Award Program has recently announced their 2020 winners. www.UnivantsHCE.com. The 2020 submissions included hospitals, commercial laboratories, reference laboratories,…
The Institute of Health Economics has two internship opportunities in our Health Economics and Industry Partnership Programs. The deadline for application is November 27th, 2020. These are made possible with support from BioTalent Canada www.biotalent.ca. Industry Partnerships – IHE Internship The focus of the internship project is on the economic evaluation of new health care…
Learn how health economics and early-stage technology assessment can support your research and development planning, raise capital, and help communicate your value proposition more clearly and effectively to payers. The IHE provides small- and medium-sized enterprises (SMEs) and innovation ecosystem partners with educational services to describe the importance of, and requirements…
IHE can serve as an economic partner in the trial of new technology in order to prepare the economic component of the evidence package required for procurement. In addition to clinical data to demonstrate the safety and efficacy of a technology, life sciences small- and medium-sized enterprises (SMEs) require health economic data and analysis to demonstrate the cost-effectiveness…
Support for market-ready life sciences companies in obtaining initial market access in a jurisdiction of interest, where the company, together with the IHE as a named economic partner, is in an improved position to engage with a procuring health system and prepare the adoption case for new technology. The IHE Life Sciences Market Access Program supports Alberta-based life sciences…
Be confident in your investment decisions - evaluate the commercial potential of healthcare technology in development through the IHE Early-Stage Life Sciences Technology Assessment service. The IHE provides services for early-stage small- and medium-sized enterprise (SME) technology developers (or other innovators, such as an academic group considering forming an SME) to present…
The Institute of Health Economics has established the Health Technology Innovation Platform (HTIP): a three (3) year, $1.8 million collaboration supported by Boehringer Ingelheim, GlaxoSmithKline, and Roche Canada, which will explore new approaches for the assessment and adoption of innovative pharmaceuticals. A…
This Rapid Review assesses the evidence on the rate of COVID-19 transmission from children to children or adults compared with the rate of transmission from adults to others, and the rate of COVID-19 infection in children compared with the rate in adults, to support return-to-school decision making. Twenty-two articles were included in the review. Based on a rapid assessment of…
Face mask use within schools has been suggested as a COVID-19 risk mitigation strategy, but the effectiveness of mask use as protection against COVID-19 transmission and infection in a school setting is currently unknown. This Rapid Review assesses the evidence on the impact of community mask use on the susceptibility to and transmission of COVID-19, and how mask use compliance…
EDMONTON, Alberta, Oct. 21, 2020 -- The health innovation community has one more approach towards increasing the timely and safe utilization of health data thanks to a research project co-sponsored by Health City and the Institute of Health Economics (IHE) in partnership with Alberta Innovates, Replica Analytics, and University of Alberta. Unique in Canada, this project was initiated…
News items are kept on the IHE website for 6 months. If you require an older news item, please contact us at [email protected] For media inquiries, please contact John Sproule, Senior Policy Director at [email protected]
IHE Health Economist, Dr, Ellen Rafferty, discusses important considerations for COVID-19 vaccine distribution with Radio Canada on October 5, 2020. (see article link at bottom of page) “Decisions will need to be made very carefully and cooperatively…. (and) communications with the public will be important. People will need…
The Institute of Health Economics is proud to be a founding partner of the international Univants of Healthcare Excellence Program https://www.univantshce.com/int/en/program along with 7 other health care organizations. The following article from the September 2020 Journal of Applied Laboratory Medicine outlines twelve diverse best practices which were recognized by the program…
Health economics evidence is not only a good business decision – it's expected. Health economics serves a critical function for life sciences small- and medium-sized enterprises (SMEs). In addition to clinical data demonstrating safety and efficacy, SMEs require health economics data and analysis to demonstrate that their innovations are cost-effective for health systems and represent…
Delay in transfer from intensive care unit (ICU) may contribute to strained capacity. Using a population-based patient cohort in 17 ICUs in Alberta between 2012 and 2016, this paper describes the epidemiologic features and healthcare costs attributable to potentially avoidable delays in ICU discharge. Potentially avoidable discharge delay occurred in approximately 70% of ICU patients…
Summary: Deliberative processes are a well-established part of health technology assessment (HTA) programs in a number of high- and middle-income countries, and serve to combine complex sets of evidence, perspectives, and values to support open, transparent, and accountable decision making. Nevertheless, there is little documentation and research to inform the development…
This study examined the temporal trends of healthcare service and medicine utilization and explored the care quality of patients with chronic low back pain (CLBP) by assessing inappropriate use of medicine, using Alberta's administrative health data from 1 April 2011 to 31 March 2018. The prevalence of CLBP in Alberta increased from 1.8% FY 2011/12 to 3.0% in FY 2017/18, and the…
There have been few epidemiological studies of dysphagia and associated outcomes using administrative datasets. In this study we estimate the proportion of patients with either stroke or head and neck cancer who are additionally diagnosed with dysphagia or aspiration pneumonia, or that have a feeding tube placed. Our analysis is based on a cohort of patients identified in administrative…
Summary: We examined the association between optimal control of dyslipidemia and mortality and healthcare costs in patients with high risk for cardiovascular disease (HRCVD) between 2012-2016 in Alberta, Canada. HRCVD patients who were optimally controlled had lower mortality and incurred modestly higher costs, compared to those who were not. Secondary prevention patients with…
If you have any questions, please contact [email protected] Email addresses for particular staff members can also be found at: https://www.ihe.ca/about/staff-directory. The Institute of Health Economics (IHE) is an independent, not-for-profit research organization that conducts health economics and health services research, performs health technology assessments, and convenes health…
